IRIS
TARZIA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.002
EU - Europa 26.850
AS - Asia 11.025
SA - Sud America 806
Continente sconosciuto - Info sul continente non disponibili 378
AF - Africa 144
OC - Oceania 39
AN - Antartide 1
Totale 72.245
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 32.532
NL - Olanda 9.521
GB - Regno Unito 6.248
CN - Cina 5.750
SG - Singapore 2.860
UA - Ucraina 2.771
IT - Italia 1.950
SE - Svezia 1.654
TR - Turchia 1.134
DE - Germania 1.067
RU - Federazione Russa 945
FI - Finlandia 942
IE - Irlanda 598
FR - Francia 590
BR - Brasile 581
VN - Vietnam 417
CA - Canada 295
IN - India 195
JP - Giappone 136
BE - Belgio 115
PL - Polonia 107
BD - Bangladesh 96
HK - Hong Kong 88
EU - Europa 80
AR - Argentina 72
ES - Italia 66
AT - Austria 61
KR - Corea 58
MX - Messico 55
IQ - Iraq 48
RO - Romania 45
CO - Colombia 44
KE - Kenya 37
ZA - Sudafrica 36
ID - Indonesia 35
AU - Australia 29
PK - Pakistan 27
CH - Svizzera 25
CL - Cile 25
EC - Ecuador 23
SA - Arabia Saudita 23
VE - Venezuela 22
HN - Honduras 20
LT - Lituania 20
CR - Costa Rica 18
IR - Iran 18
JM - Giamaica 18
PH - Filippine 17
TG - Togo 16
AL - Albania 15
MA - Marocco 14
MY - Malesia 12
PE - Perù 12
EE - Estonia 11
NP - Nepal 11
PY - Paraguay 11
GR - Grecia 10
JO - Giordania 10
TT - Trinidad e Tobago 10
AE - Emirati Arabi Uniti 9
DK - Danimarca 9
HU - Ungheria 9
NZ - Nuova Zelanda 9
PR - Porto Rico 9
SV - El Salvador 9
UZ - Uzbekistan 9
AZ - Azerbaigian 8
CW - ???statistics.table.value.countryCode.CW??? 8
GT - Guatemala 8
IL - Israele 8
DZ - Algeria 7
PT - Portogallo 7
BG - Bulgaria 6
BO - Bolivia 6
EG - Egitto 6
ET - Etiopia 6
HR - Croazia 6
KG - Kirghizistan 6
KZ - Kazakistan 6
LA - Repubblica Popolare Democratica del Laos 6
NI - Nicaragua 6
RS - Serbia 6
UY - Uruguay 6
AM - Armenia 5
LU - Lussemburgo 5
LV - Lettonia 5
MD - Moldavia 5
OM - Oman 5
SM - San Marino 5
TN - Tunisia 5
TW - Taiwan 5
BB - Barbados 4
CZ - Repubblica Ceca 4
LB - Libano 4
PA - Panama 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
Totale 71.894
Salva come PNG Salva come JPEG
Città #
Amsterdam 9.481
Southend 5.676
Dallas 4.226
Woodbridge 3.101
Ashburn 2.365
Ann Arbor 2.233
Jacksonville 2.216
Houston 2.138
Chandler 1.869
Fairfield 1.852
San Jose 1.709
Singapore 1.469
Nanjing 1.223
Cambridge 898
Izmir 876
Wilmington 828
Beijing 757
Seattle 720
Boardman 547
Dublin 539
Council Bluffs 524
Nanchang 465
Helsinki 381
San Mateo 345
New York 329
Princeton 320
Lauterbourg 282
Düsseldorf 255
Los Angeles 250
Hebei 249
Shenyang 242
Santa Clara 221
Tianjin 220
Changsha 200
Jiaxing 186
Kunming 162
Moscow 158
Istanbul 147
Munich 136
Des Moines 134
Velikiy Novgorod 125
Ho Chi Minh City 121
Toronto 116
Brussels 112
Shanghai 111
Milan 98
Hanoi 97
San Francisco 95
Mülheim 93
Buffalo 92
San Diego 89
São Paulo 87
Urbino 83
Bremen 81
Chicago 80
Jinan 79
Hangzhou 78
London 75
Orem 75
Guangzhou 73
Hong Kong 72
Frankfurt am Main 69
Orciano Di Pesaro 61
Lanzhou 59
Montreal 59
Rome 58
Zhengzhou 58
Changchun 57
Venice 57
Dong Ket 54
Ningbo 53
Tokyo 53
Nuremberg 52
Stockholm 52
Warsaw 52
Brooklyn 48
Menlo Park 48
Seongnam 45
Atlanta 43
Phoenix 43
Vienna 42
Dearborn 41
Denver 40
Kraków 40
Norwalk 38
Turku 38
Haikou 36
Chennai 34
Shenzhen 34
Secaucus 29
Johannesburg 27
Taizhou 27
Auburn Hills 26
Manchester 26
The Dalles 26
Wuppertal 26
Charlotte 25
Augusta 24
Nairobi 24
Naples 24
Totale 53.509
Salva come PNG Salva come JPEG
Nome #
1-(2-Alkylamidoethyl)-6-methoxyindole Derivatives: A New Class of Potent Indole Melatonin Analogues. 3.214
1-Aminocyclopropane-1-carboxylic acid derivatives as ligands at the glicine-site of the NMDA receptor. 3.210
1,5-BENZODIAZEPINE-2,4-DIONE GASTRIN AND CHOLECYSTOKININ-B-RECEPTOR ANTAGONISTS 3.175
1,7-DIHYDROPYRROLO[3,4-e][1,4]DIAZEPIN-2(3H)-ONE DERIVATIVES, AND THEIR USE AS ANTICONVULSANT AND ANTIANXIETY AGENTS 3.166
SULLA MICELIANAMMIDE 2.138
Inibitori dell’enzima NAAA (N-Acylethanolamine-Hydrolizing Acid Amidase) come nuovi agenti antinfiammatori 883
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 882
1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DERIVATIVES AS LIGANDS AT THE GLYCINE-BINDING SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR 443
Scoperta del primo inibitore dell’enzima idrolasi delle ammidi degli acidi grassi (FAAH) ad azione periferica 367
Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties 320
The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3’-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice 320
Cyclohexylcarbamic Acid 3’-or 4’-Substituted Biphenyl-3-yl Esters as Fatty Acid Amide Hydrolase Inhibitors: Synthesis Quantitative Structure–Activity Relationships, and Molecular Modeling Studies 307
(E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists. 299
Divergent synthesis of novel 9-deazaxanthine derivatives via late-stage cross-coupling reactions 298
Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress 296
ORGANIC REACTIONS OF FLUOROXY COMPOUNDS: ADDITION REACTIONS OF UNACTIVATED AND DEACTIVATED UNSATURATED LINKAGES OF STEROIDS 294
3-(2-Carbamoylvinyl)-4,5-dimethylpyrrole-2-carboxylic acids as ligands at the NMDA glycine-binding site: a study on the 2-carbamoylvinyl chain modification 293
A Second Generation of Carbamate-Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivo 293
Sintesi e studi di relazione struttura-attività/stabilità di carbammati inibitori dell’enzima FAAH 291
Tricyclic Alkylamides as Melatonin Receptor Ligands with Antagonist or Inverse Agonist Activity 286
A new melatonin receptor ligand with mt1-agonist and MT2-antagonist properties 285
2-n-Butyl- 9-methyl-8-(1,2,3)triazol-2-yl-9H-purin-6-ylamine and Analogues as A2A Adenosine Receptor Antagonists. Design, Synthesis, and Pharmacological Characterization 283
Synthesis and Biological Activity of new melatonin dimeric derivatives. 282
4,5-Dihydroisoxazole and 4,5-dihydro-1,2,4-oxadiazole derivatives from cycloaddition reactions of nitrile oxides to alkyl N-(diphenylmethylene)-α ,β -dehydroamino acids 282
Potent, Metabolically Stable 2-Alkyl-8-(2H-1,2,3-triazol-2-yl)-9H-adenines as Adenosine A2A Receptor Ligands 281
ENOLATES OF 17,20:20,21-BISMETHYLENEDIOXYPREDNISONE 280
Synthesis of benzo[1,2-d;3,4-d’]diimidazole and 1H-pyrazolo[4,3-b]pyridine as putative A2A receptor antagonists 279
An improved route to cycloalka[b]pyrrole 2-carboxylates 276
Structure–Property Relationships of a Class of Carbamate-Based Fatty Acid Amide Hydrolase (FAAH) Inhibitors: Chemical and Biological Stability 276
Alkyl 2 (Diphenyl-methyleneamino) acrylates in the Synthesis of α-Amino Acids 271
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: Steric effects of N-alkyl chain on rat plasma and liver stability 271
5-(2-Ethyl-phenyl)-3-(3-methoxy-phenyl)-1H-[1,2,4]triazole (DL-111-IT ) and related compounds induce morphological apoptotic patterns in cultures of human tumor cell lines 264
Synthesis and Biological Evaluation of Metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535), A Potent Antagonist of the A2AAdenosine Receptor for the Treatment of Parkinson’s Disease 264
10-(1-HYDROXYMETHYL)-11-OXO-1-AZATRICYCLOUNDEC-2-ENE-2-CARBOXYLIC ACID ESTERS USEFUL AS ANTIBACTERIAL AND PROCESS FOR THEIR PREPARATION 261
Identification of a Bioactive Impurity in a Commercial Sample of 6-Methyl-2-p-tolylaminobenzo[d][1,3]oxazin-4-one (URB754) 261
Reassessing the melatonin pharmacophore: enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue. 259
N-(Substituted-anilinoethyl)acylamides: Design, Synthesis and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands 255
"Hot spots" in Medicinal Chemistry 254
2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists 254
2,4,5-TRISUBSTITUTED OXAZOLES 251
Application of a non-electrophysiological method to study binding affinity and efficacy of glicine analogs to the glicine site of the NMDA receptor-ion channel complex. 250
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation 250
Anandamide suppressess pain initiation through a peripheral endocannabinoid mechanism 248
POSITIVE ION-MASS SPECTRA AND COLLISION-INDUCED DISSOCIATION OF SOME 2,3-DIDEHYDRO AMINO ACIDS 243
N (Diphenylmethylene)-α,β−didehydroamino Acid Esters. Thermal and Lewis Acid Induced Dimerizations 243
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands. 242
Modulation of Anxiety Through Blockade of Anandamide Hydrolysis 240
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 240
2,3-Dehydroamino acid derivatives as intermediates in the synthesis of heterocyclic compounds. 239
An endocannabinoid mechanism for stress-induced analgesia 234
Bivalent Ligand Approach on N-[2-[(3-methoxyphenyl)methylamino]ethyl]acetamide. Synthesis, Binding Affinity and Intrinsic Acivity for MT(1) and MT(2) melatonin Receptors. 233
Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand 233
Design and synthesis of N-[3,3-diphenyl-propenyl]alkanamides as a novel class of potent MT2-selective Melatonin receptor ligands 232
(E)-3-[2-(Carbamoylvinyl)]pyrrol-2-carboxylic acid derivatives: A novel Class of glycine site Antagonists. 232
2,4-Dicarboxy-pyrroles as Selective Non-Competitive mGluR1 Antagonists: an exploration of the role of the pyrrolic scaffold 231
N-acetiltriptamine 2,5-sostituite: sintesi e valutazione dell’attività biologica per i recettori melatoninergici MT1 e MT2 230
TEICOPLANIN HYDRAZIDES AS ANTIBACTERIALS 230
5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors, preparation, and therapeutic use.. 230
2,3-Dihydro-6,7-dichloro-pyrido[2,3-b]pyrazine-8-oxide as Selective Glycine Antagonist with in vivo Activity. 229
Conformationally Restrained Melatonin Analogs: Synthesis, Binding Affinity for the Melatonin Receptor, Evaluation of the Biological Activity, and Molecular Modeling Study 229
O-Biphenyl-3-yl Carbamates as Peripheral FAAH Inhibitors: Synthesis and Structure–Activity (SAR) Relationship Studies 228
Differentiation between isomeric 1-aminocyclopropane-1-carboxylic acid derivatives by means of chemical ionisation and mass selected collision induced dissociation 227
X-RAY STRUCTURE DETERMINATION OF MEXIPROSTIL, A NEW GASTROPROTECTIVE 16-METHOXY-16METHYL-PGE1 ANALOGUE 226
3,6-DISUBSTITUTED TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES 225
Mechanisms of action and antiproliferative properties of URB631 in human breast cancer 223
N-(DIPHENYLMETHYLENE)-ALPHA,BETA-DIDEHYDROAMINO ACID ESTERS. THERMAL AND LEWIS ACID INDUCED DIMERIZATIONS 221
Synthesis and Structure–Activity Relationships of a Series of Pyrrole Cannabinoid Receptor Agonists 221
Peripherally Restricted FAAH Inhibitors 221
Toward the Definition of Stereochemical Requirements for MT(2)-Selective Antagonists and Partial Agonists by Studying 4-Phenyl-2-propionamidotetralin Derivatives 221
2-N-Acylaminoalkylindoles: Design and Quantitative Structure-Activity Relationship Studies Leading to MT2-Selective Antagonists. 220
MT1-Selective Melatonin Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Dynamics Investigation of N-{[(3-O-Substituted)anilino]alkyl}amides 220
N-Acyl-5- and -2,5-substituted tryptamines: synthesis, activity and affinity for human mt1 and MT2 melatonin receptors 218
(2-AMINOETHYL)IMIDAZOLES.SYNTHESIS OF 1,4-DIMETHYL-5-PHENYL-2-[2-(4-PHENYLPIPERAZINYL)ETHYL]IMIDAZOLE 218
Plant-derived phenolic compounds prevent the DNA single-strand breakage and cytotoxicity induced by tert-butylhydroperoxide via an iron-chelating mechanism. 218
Synthesis and Structure–Activity Relationship (SAR) of 2-Methyl-4-oxo-3-oxetanyl Carbamic Acid Esters, a Class of Potent N-Acylethanolamine Acid Amidase (NAAA) Inhibitors 218
Synthesis, Enantiomeric Resolution and Structure-Activity Relationship Study for a Series of 10,11-Dihydro-5H-dibenzo[a,d]cycloheptene MT2 Receptor Antagonists. 217
Synthesis of (E)-8-(3-Chlorostyryl)caffeine Analogues Leading to 9-Deazaxanthine Derivatives as Dual A2AAntagonists/MAO-B Inhibitors 216
GENERALISED ELECTROPHILIC FLUORINATION BY FLUOROXY COMPOUNDS 214
Synthesis and Quantitative Structure–Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates 213
MELATONIN RECEPTOR AGONISTS: SAR AND APPLICATIONS TO THE TREATMENT OF SLEEP-WAKE DISORDERS 211
2-(1,1'-BIPHEN-4-YL)-1,2,4-TRIAZOLE[5,1-a]ISOQUINOLINE (L-14105), A POTENTIAL ORALLY ACTIVE CONTRAGESTATIONAL AGENT FOR THE BITCH: STUDIES IN THE RAT, HAMSTER AND DOG 211
Sintesi e studi biologici preliminari su analoghi di URB937, il primo inibitore ad azione periferica dell'enzima FAAH 210
SYNTHESIS, BINDING AFFINITY FOR THE MELATONIN RECEPTOR, AND EVALUATION OF THE BIOLOGICAL ACTIVITY OF NEW INDOLE-BASED MELATONIN ANALOGUES. 210
Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain 209
ANGIOTENSIN CONVERTING ENZYME INHIBITORS AS ANTIHYPERTENSIVE AGENTS: 1-[´2-MERCAPTOCYCLOALKYL`CARBONYL]-L-PROLINES 208
Alchilammidi tricicliche: legandi selettivi dei recettori melatoninergici MT1 e MT2 208
SUITABILITY OF FAST-ION BOMBARDMENT MASS SPECTROMETRY FOR THE INVESTIGATION OF 11,4-DIHYDROPYRIDINE DERIVATIVES 207
2 - Arachidonoylglycerol and anandamide are endocannabinoid mediators of stress - induced analgesia 207
Pharmacological characterization of hydrolysis resistano analogs of oleoylethanolamide with potent anorexiant properties 206
Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models 206
Design, Synthesis and Structure–Activity Relationships of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acid Amide Hydrolase Inhibitors 205
SYNTHESIS AND BIOLOGICAL PROPERTIES OF N63-CARBOXAMIDES OF TEICOPLANIN ANTIBIOTICS. STRUCTURE-ACTIVITY RELATIONSHIPS. 202
UNIVERSITY EDUCATION OF MEDICINAL CHEMISTS: COMPARISON OF EIGHT COUNTRIES 201
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus 201
Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepam 201
Melatonin antagonizes apoptosis via receptor interaction in U937 monocytic cell 201
URB602 Inhibits Monoacylglycerol Lipase and Selectively Blocks 2-Arachidonoylglycerol Degradation in Intact Brain Slices 200
Modulation of anxiety through blockade of anandamide hydrolysis 200
Melatonin prevents apoptosis induced by UV-B treatment in U937 cell line. 199
6-(ALKYLAMINO)-3-ARYL-1,2,4-TRIAZOLO[3,4-A]PHTHALAZINES. A NEW CLASS OF BENZODIAZEPINE RECEPTOR LIGANDS 199
Totale 39.389
Salva come PNG Salva come JPEG
Categoria #
all - tutte 215.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 215.262
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.274 0 0 0 514 74 84 111 202 219 136 41 893
2022/20235.271 613 291 153 643 460 1.157 15 428 868 137 354 152
2023/20241.271 165 132 78 157 81 294 65 80 19 88 22 90
2024/20254.519 285 248 1.123 275 98 424 452 305 369 254 376 310
2025/202623.048 769 2.014 3.712 1.659 789 808 1.428 354 10.008 673 608 226
2026/20273.203 999 246 1.045 913 0 0 0 0 0 0 0 0
Totale 72.245